Improved assay for quantifying a redox form of angiotensinogen as a biomarker for pre-eclampsia: A case-control study

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Rahgozar, Soheila ^a   Amirian, Tayebeh ^a   Qi, Miao ^b   Shahshahan, Zahra ^c   Entezar E Ghaem, Mansureh ^a   Tehrani, Hatav Ghasemi ^c   Miroliaei, Mehran ^a   Krilis, Steven A ^b   Giannakopoulos, Bill ^b  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ST GEORGE HOSPITAL   (Australia)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER; THIOL;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PROTEIN BLOOD LEVEL; BIOASSAY; BLOOD; CHEMISTRY; COMPARATIVE STUDY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC;

ADULT; ANGIOTENSINOGEN; BIOLOGICAL ASSAY; BIOMARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; ROC CURVE;

EID: 84943230566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135905     Document Type: Article

References (30)

1. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365: 785-799. PMID: 15733721
2. Curtin WM, Weinstein L (1999) A review of HELLP syndrome. J Perinatol 19: 138-143. PMID: 10642976
3. Sibai BM (2011) Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 205: 191-198. doi: 10.1016/j.ajog.2011.07.017 PMID: 22071049
4. Khong TY, De Wolf F, Robertson WB, Brosens I (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93: 1049-1059. PMID: 3790464
5. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A (1994) A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 101: 669-674. PMID: 7947500
6. Hung TH, Burton GJ (2006) Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 45: 189-200. PMID: 17175463
7. Raijmakers MT, Zusterzeel PL, Roes EM, Steegers EA, Mulder TP, et al. (2001) Oxidized and free whole blood thiols in preeclampsia. Obstet Gynecol 97: 272-276. PMID: 11165594
8. Guang C, Phillips RD, Jiang B, Milani F (2012) Three key proteases - angiotensin-I-converting enzyme (ACE), ACE2 and renin - within and beyond the renin-angiotensin system. Arch Cardiovasc Dis 105: 373-385. doi: 10.1016/j.acvd.2012.02.010 PMID: 22800722
9. Sigmund CD (2010) Structural biology: On stress and pressure. Nature 468: 46-47. doi: 10.1038/468046a PMID: 21048758
10. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, et al. (2010) A redox switch in angiotensinogen modulates angiotensin release. Nature 468: 108-111. doi: 10.1038/nature09505 PMID: 20927107
11. ACOG (2013) Hypertension in Pregnancy Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Executive Summary. The American College of Obstetricians and Gynecologists 122: 1122-1131.
12. Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, et al. (2010) Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Blood 116: 1995-1997. doi: 10.1182/blood-2010-02-271494 PMID: 20847215
13. Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JW, et al. (2010) Redox control of beta2-glycoprotein I-von Willebrand factor interaction bythioredoxin-1. JThromb Haemost 8: 1754-1762. doi: 10.1111/j.1538-7836.2010.03944.x PMID: 20979592
14. Giannakopoulos B, Gao L, Qi M, Wong JW, Yu DM, et al. (2012) Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. J Autoimmun 39: 121-129. doi: 10.1016/j.jaut.2012.05.005 PMID: 22704541
15. Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, et al. (2011) Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I. Arthritis Rheum 63: 2774-2782. doi: 10.1002/art.30383 PMID: 21618459
16. Lamminpaa R, Vehvilainen-Julkunen K, Gissler M, Heinonen S (2012) Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth 12: 47. doi: 10.1186/1471-2393-12-47 PMID: 22687260
17. Ozalp S, Tanir HM, Sener T, Yazan S, Keskin AE (2003) Health risks for early (< or = 19) and late (>or = 35)childbearing. Arch Gynecol Obstet 268: 172-174. PMID: 12942245
18. Jacobsson B, Ladfors L, Milsom I (2004) Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 104: 727-733. PMID: 15458893
19. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF (2006) WHO analysis of causes of maternal death: asystematic review. Lancet 367: 1066-1074. PMID: 16581405
20. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, et al. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355: 992-1005. PMID: 16957146
21. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, et al. (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354: 810-816. PMID: 10485722
22. Villar J, Purwar M, Merialdi M, Zavaleta N, Thi Nhu Ngoc N, et al. (2009) World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG 116: 780-788. doi: 10.1111/j.1471-0528.2009.02158.x PMID: 19432566
23. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM (2005) Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 192: 520-521. PMID: 15695996
24. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH, et al. (2006) Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIPtrial): randomised placebo-controlled trial. Lancet 367: 1145-1154. PMID: 16616557
25. Spinnato JA 2nd, Freire S, Pinto ESJL, Cunha Rudge MV, Martins-Costa S, et al. (2007) Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol 110: 1311-1318. PMID: 18055726
26. Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, et al. (2010) An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 202: 239 e231-239 e210.
27. Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, et al. (2010) Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 362: 1282-1291. doi: 10.1056/NEJMoa0908056 PMID: 20375405
28. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS, et al. (2006) Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354: 1796-1806. PMID: 16641396
29. Kobori H, Nangaku M, Navar LG, Nishiyama A (2007) The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287. PMID: 17878513
30. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, et al. (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417-1427. PMID: 12045255